Review




Structured Review

AnaSpec recombinant human endothelin 1 (et1)
Recombinant Human Endothelin 1 (Et1), supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+endothelin+1+(et1)/recombinant+human+endothelin+1++et1+/10__1080_slash_2162402x__2017__1326442-204-32-38
Average 90 stars, based on 1 article reviews
recombinant human endothelin 1 (et1) - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

In Vitro:

Article Title: Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
Article Snippet: T cells were mixed at different ratios with MBL-2 target cells, and after 5 h of co-culture, the supernatants were harvested to measure 51 Cr release. .. In vitro cell assays For lymphocyte-endothelial adhesion assays, human umbilical vein endothelial cells (HUVECs) were grown to 40% confluence in 96-well plates (Biocoat lab) in EGM2 medium (Cambrex) and treated with recombinant human endothelin 1 (ET1; 10 nM, Anaspec), BQ-788 (200 nM-American Peptide Company), C5aR1A (20 M), Compstatin-analogue CP30 71 (100 M), or control peptide for 24 h, followed by the addition of TNF-α (20 ng/ml, Sigma) for 4 h. Where indicated, HUVECs cells were stimulated with 50 ng/ml of recombinant C5a (Sigma) according to literature 72, 73 . .. Control HUVECs were kept in EGM2 medium (Cambrex) or treated with TNF-α alone.

Recombinant:

Article Title: Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
Article Snippet: T cells were mixed at different ratios with MBL-2 target cells, and after 5 h of co-culture, the supernatants were harvested to measure 51 Cr release. .. In vitro cell assays For lymphocyte-endothelial adhesion assays, human umbilical vein endothelial cells (HUVECs) were grown to 40% confluence in 96-well plates (Biocoat lab) in EGM2 medium (Cambrex) and treated with recombinant human endothelin 1 (ET1; 10 nM, Anaspec), BQ-788 (200 nM-American Peptide Company), C5aR1A (20 M), Compstatin-analogue CP30 71 (100 M), or control peptide for 24 h, followed by the addition of TNF-α (20 ng/ml, Sigma) for 4 h. Where indicated, HUVECs cells were stimulated with 50 ng/ml of recombinant C5a (Sigma) according to literature 72, 73 . .. Control HUVECs were kept in EGM2 medium (Cambrex) or treated with TNF-α alone.

Article Title: Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
Article Snippet: T cells were mixed at different ratios with MBL-2 target cells, and after 5 h of co-culture, the supernatants were harvested to measure 51 Cr release. .. For lymphocyte–endothelial adhesion assays, HUVECs were grown to 40% confluence in 96-well plates (Biocoat laboratory) in EGM2 medium (Cambrex) and treated with recombinant human endothelin 1 (ET1; 10 nM, Anaspec), BQ-788 (200 nM-American Peptide Company), C5aR1A (20 μM), Compstatin-analog CP30 71 (100 μM), or control peptide for 24 h, followed by the addition of TNF-α (20 ng/mL, Sigma) for 4 h. Where indicated, HUVECs cells were stimulated with 50 ng/mL of recombinant C5a (Sigma) according to literature. .. Control HUVECs were kept in EGM2 medium (Cambrex) or treated with TNF-α alone.

Control:

Article Title: Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
Article Snippet: T cells were mixed at different ratios with MBL-2 target cells, and after 5 h of co-culture, the supernatants were harvested to measure 51 Cr release. .. In vitro cell assays For lymphocyte-endothelial adhesion assays, human umbilical vein endothelial cells (HUVECs) were grown to 40% confluence in 96-well plates (Biocoat lab) in EGM2 medium (Cambrex) and treated with recombinant human endothelin 1 (ET1; 10 nM, Anaspec), BQ-788 (200 nM-American Peptide Company), C5aR1A (20 M), Compstatin-analogue CP30 71 (100 M), or control peptide for 24 h, followed by the addition of TNF-α (20 ng/ml, Sigma) for 4 h. Where indicated, HUVECs cells were stimulated with 50 ng/ml of recombinant C5a (Sigma) according to literature 72, 73 . .. Control HUVECs were kept in EGM2 medium (Cambrex) or treated with TNF-α alone.

Article Title: Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
Article Snippet: T cells were mixed at different ratios with MBL-2 target cells, and after 5 h of co-culture, the supernatants were harvested to measure 51 Cr release. .. For lymphocyte–endothelial adhesion assays, HUVECs were grown to 40% confluence in 96-well plates (Biocoat laboratory) in EGM2 medium (Cambrex) and treated with recombinant human endothelin 1 (ET1; 10 nM, Anaspec), BQ-788 (200 nM-American Peptide Company), C5aR1A (20 μM), Compstatin-analog CP30 71 (100 μM), or control peptide for 24 h, followed by the addition of TNF-α (20 ng/mL, Sigma) for 4 h. Where indicated, HUVECs cells were stimulated with 50 ng/mL of recombinant C5a (Sigma) according to literature. .. Control HUVECs were kept in EGM2 medium (Cambrex) or treated with TNF-α alone.



Similar Products

90
AnaSpec recombinant human endothelin 1 (et1)
Recombinant Human Endothelin 1 (Et1), supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+endothelin+1+(et1)/recombinant+human+endothelin+1++et1+/10__1080_slash_2162402x__2017__1326442-204-32-38
Average 90 stars, based on 1 article reviews
recombinant human endothelin 1 (et1) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results